Interleukin-28B polymorphisms and response of chronic hepatitis C patients from Indonesia to pegylated interferon/ribavirin treatment

J. Juniastuti; Bogi P. Wibowo; I. D.N. Wibawa; Takako Utsumi; Syifa Mustika; Mochamad Amin; Rury M. Wahyuni; Hendra Kurniawan; Agus Hendrayana; Poernomo B. Setiawan; Laura N. Yamani; S. Soetjipto; Yoshihiko Yano; Hak Hotta; Yoshitake Hayashi; Maria I. Lusida

doi:10.1128/JCM.00768-14

Interleukin-28B polymorphisms and response of chronic hepatitis C patients from Indonesia to pegylated interferon/ribavirin treatment

J. Juniastuti
, Bogi P. Wibowo
, I. D.N. Wibawa
, Takako Utsumi
, Syifa Mustika
, Mochamad Amin
, Rury M. Wahyuni
, Hendra Kurniawan
, Agus Hendrayana
, Poernomo B. Setiawan
, Laura N. Yamani
, S. Soetjipto
, Yoshihiko Yano
, Hak Hotta
, Yoshitake Hayashi
, Maria I. Lusida^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Abstract

This study demonstrated that Indonesian patients with chronic hepatitis C (mostly ethnic Java people) mostly were infected with hepatitis C virus (HCV) genotype 1; however, they carried mainly the major genotypes of interleukin 28B (IL-28B) single nucleotide polymorphisms (SNPs) (rs12979860 CC, rs11881222 TT, rs8103142 AA, and rs8099917 TT), and they mostly achieved sustained virological responses to pegylated interferon/ribavirin treatment.

Original language	English
Pages (from-to)	2193-2195
Number of pages	3
Journal	Journal of Clinical Microbiology
Volume	52
Issue number	6
DOIs	https://doi.org/10.1128/JCM.00768-14
Publication status	Published - Jun 2014
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1128/JCM.00768-14

Cite this

Juniastuti, J., Wibowo, B. P., Wibawa, I. D. N., Utsumi, T., Mustika, S., Amin, M., Wahyuni, R. M., Kurniawan, H., Hendrayana, A., Setiawan, P. B., Yamani, L. N., Soetjipto, S., Yano, Y., Hotta, H., Hayashi, Y., & Lusida, M. I. (2014). Interleukin-28B polymorphisms and response of chronic hepatitis C patients from Indonesia to pegylated interferon/ribavirin treatment. Journal of Clinical Microbiology, 52(6), 2193-2195. https://doi.org/10.1128/JCM.00768-14

@article{9ca982d3baf8418ab738e6082efed1ba,

title = "Interleukin-28B polymorphisms and response of chronic hepatitis C patients from Indonesia to pegylated interferon/ribavirin treatment",

abstract = "This study demonstrated that Indonesian patients with chronic hepatitis C (mostly ethnic Java people) mostly were infected with hepatitis C virus (HCV) genotype 1; however, they carried mainly the major genotypes of interleukin 28B (IL-28B) single nucleotide polymorphisms (SNPs) (rs12979860 CC, rs11881222 TT, rs8103142 AA, and rs8099917 TT), and they mostly achieved sustained virological responses to pegylated interferon/ribavirin treatment.",

author = "J. Juniastuti and Wibowo, \{Bogi P.\} and Wibawa, \{I. D.N.\} and Takako Utsumi and Syifa Mustika and Mochamad Amin and Wahyuni, \{Rury M.\} and Hendra Kurniawan and Agus Hendrayana and Setiawan, \{Poernomo B.\} and Yamani, \{Laura N.\} and S. Soetjipto and Yoshihiko Yano and Hak Hotta and Yoshitake Hayashi and Lusida, \{Maria I.\}",

year = "2014",

month = jun,

doi = "10.1128/JCM.00768-14",

language = "English",

volume = "52",

pages = "2193--2195",

journal = "Journal of Clinical Microbiology",

issn = "0095-1137",

publisher = "American Society for Microbiology",

number = "6",

}

Juniastuti, J, Wibowo, BP, Wibawa, IDN, Utsumi, T, Mustika, S, Amin, M, Wahyuni, RM, Kurniawan, H, Hendrayana, A, Setiawan, PB, Yamani, LN, Soetjipto, S, Yano, Y, Hotta, H, Hayashi, Y & Lusida, MI 2014, 'Interleukin-28B polymorphisms and response of chronic hepatitis C patients from Indonesia to pegylated interferon/ribavirin treatment', Journal of Clinical Microbiology, vol. 52, no. 6, pp. 2193-2195. https://doi.org/10.1128/JCM.00768-14

TY - JOUR

T1 - Interleukin-28B polymorphisms and response of chronic hepatitis C patients from Indonesia to pegylated interferon/ribavirin treatment

AU - Juniastuti, J.

AU - Wibowo, Bogi P.

AU - Wibawa, I. D.N.

AU - Utsumi, Takako

AU - Mustika, Syifa

AU - Amin, Mochamad

AU - Wahyuni, Rury M.

AU - Kurniawan, Hendra

AU - Hendrayana, Agus

AU - Setiawan, Poernomo B.

AU - Yamani, Laura N.

AU - Soetjipto, S.

AU - Yano, Yoshihiko

AU - Hotta, Hak

AU - Hayashi, Yoshitake

AU - Lusida, Maria I.

PY - 2014/6

Y1 - 2014/6

N2 - This study demonstrated that Indonesian patients with chronic hepatitis C (mostly ethnic Java people) mostly were infected with hepatitis C virus (HCV) genotype 1; however, they carried mainly the major genotypes of interleukin 28B (IL-28B) single nucleotide polymorphisms (SNPs) (rs12979860 CC, rs11881222 TT, rs8103142 AA, and rs8099917 TT), and they mostly achieved sustained virological responses to pegylated interferon/ribavirin treatment.

AB - This study demonstrated that Indonesian patients with chronic hepatitis C (mostly ethnic Java people) mostly were infected with hepatitis C virus (HCV) genotype 1; however, they carried mainly the major genotypes of interleukin 28B (IL-28B) single nucleotide polymorphisms (SNPs) (rs12979860 CC, rs11881222 TT, rs8103142 AA, and rs8099917 TT), and they mostly achieved sustained virological responses to pegylated interferon/ribavirin treatment.

UR - https://www.scopus.com/pages/publications/84901660367

U2 - 10.1128/JCM.00768-14

DO - 10.1128/JCM.00768-14

M3 - Article

C2 - 24696021

AN - SCOPUS:84901660367

SN - 0095-1137

VL - 52

SP - 2193

EP - 2195

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

IS - 6

ER -

Interleukin-28B polymorphisms and response of chronic hepatitis C patients from Indonesia to pegylated interferon/ribavirin treatment

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this